PROCESS FOR PREPARING BIOACTIVE COMPLEXES OF HEDERA HELIX HERBA AND MEDICINE PRODUCT TO BE USED IN ANTI-TUMOUR THERAPY

摘要

The invention relates to a phytotherapeutic product, a process for preparing the same and a medicine containing the same, used in the anti-tumor therapy. According to the invention, the phytotherapeutic product contains at least 90% of total triterpene monodesmoside saponins, aglycon hederagenin, of which 70...80% alpha-hederin, usable for preparing some bioactive intermediates. According to the invention, the process consists in the liquid/liquid extraction of a triterpene glycosides complex from Hedera Helix plant, in which the alpha-hederin is first separated by a liquid/liquid extraction with ethyl acetate, followed by the separation of bisdesmosidic glycoside compounds Hederacoside C, of which there result two purified preparations, a liquid bioactive complex and an aqueous CuNa-chlorophyl extract. According to the invention, the medicine product comprises 1...2% phytotherapeutic product conditioned with pharmaceutically acceptable ingredients, suitable to the administration type.